![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/soligenix-announces-positive-clinical-results-from-a-comparative-study-evaluating-hybryte-against-valchlor-in-the-treatment-of-cutaneous-t-cell-lymphoma-302181378.html
https://www.prnewswire.com/news-releases/soligenix-announces-reverse-stock-split-302160182.html
https://www.prnewswire.com/news-releases/soligenix-announces-recent-accomplishments-and-first-quarter-2024-financial-results-302141925.html
https://www.prnewswire.com/news-releases/soligenix-to-present-at-upcoming-conferences-302136163.html
https://www.prnewswire.com/news-releases/soligenix-extends-patent-protection-for-its-filovirus-vaccine-platform-to-the-united-kingdom-and-south-africa-302127074.html
https://www.prnewswire.com/news-releases/soligenix-announces-pricing-of-4-75-million-public-offering-302120465.html
https://www.prnewswire.com/news-releases/fda-grants-soligenix-orphan-drug-designation-for-the-prevention-and-post-exposure-prophylaxis-against-marburg-marburgvirus-infection-302115205.html
https://www.prnewswire.com/news-releases/fda-grants-soligenix-orphan-drug-designation-for-the-prevention-and-post-exposure-prophylaxis-against-sudan-ebolavirus-infection-302113685.html
https://www.biospace.com/article/releases/fda-grants-soligenix-orphan-drug-designation-for-the-prevention-and-post-exposure-prophylaxis-against-sudan-ebolavirus-infection/